GLP-1 obesity drugs benefit the heart but may cause muscle loss

GLP-1 drugs used primarily to treat obesity and diabetes may affect the body far more broadly than initially thought, researchers say. Studies point to possible cardiovascular and muscle benefits, but also flag risks of muscle mass loss and nutritional deficiencies in patients using the medications.